Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Frailty Characteristics in Chronic HIV Patients are Markers of White Matter Atrophy Independently of Age and Depressive Symptoms: A Pilot Study.

Kallianpur KJ, Sakoda M, Gangcuangco LM, Ndhlovu LC, Umaki T, Chow D, Wongjittraporn S, Shikuma CM.

Open Med J. 2016;3:138-152. Epub 2016 Aug 29.

2.

Oxidative mitochondrial DNA damage in peripheral blood mononuclear cells is associated with reduced volumes of hippocampus and subcortical gray matter in chronically HIV-infected patients.

Kallianpur KJ, Gerschenson M, Mitchell BI, LiButti DE, Umaki TM, Ndhlovu LC, Nakamoto BK, Chow DC, Shikuma CM.

Mitochondrion. 2016 May;28:8-15. doi: 10.1016/j.mito.2016.02.006. Epub 2016 Feb 23.

3.

Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND).

Ndhlovu LC, Umaki T, Chew GM, Chow DC, Agsalda M, Kallianpur KJ, Paul R, Zhang G, Ho E, Hanks N, Nakamoto B, Shiramizu BT, Shikuma CM.

J Neurovirol. 2014 Dec;20(6):571-82. doi: 10.1007/s13365-014-0279-x. Epub 2014 Sep 17.

4.

Poorer neuropsychological performance increases risk for social services among HIV-infected individuals.

Umaki TM, Gangcuangco LM, Chow DC, Nakamoto BK, Marotz L, Kallianpur KJ, Shikuma CM.

Hawaii J Med Public Health. 2013 Dec;72(12):422-6.

5.

Feasibility and potential role of ferumoxytol-enhanced neuroimaging in HIV-associated neurocognitive disorder.

Nakamoto BK, Shikuma CM, Ogata-Arakaki D, Umaki T, Neuwelt EA, Shiramizu BT, Chow DC, Parikh NI, Kallianpur KJ, Hamilton BE.

J Neurovirol. 2013 Dec;19(6):601-5. doi: 10.1007/s13365-013-0213-7. Epub 2013 Oct 16.

6.

Albuminuria as a marker of cardiovascular risk in HIV-infected individuals receiving stable antiretroviral therapy.

Tongma C, Shikuma CM, Nakamoto BK, Kallianpur KJ, Umaki TM, Barbour JD, Ndhlovu L, Parikh NI, Chow DC.

Hawaii J Med Public Health. 2013 Sep;72(9 Suppl 4):34-8.

7.

Predictors of 25-hydroxyvitamin D levels in HIV-infected patients in Hawai'i.

Gangcuangco LM, Chow DC, Liang CY, Nakamoto BK, Umaki TM, Kallianpur KJ, Shikuma CM.

Hawaii J Med Public Health. 2013 Jun;72(6):197-201.

8.

Soluble interleukin-6 receptor is a serum biomarker for the response of esophageal carcinoma to neoadjuvant chemoradiotherapy.

Makuuchi Y, Honda K, Osaka Y, Kato K, Kojima T, Daiko H, Igaki H, Ito Y, Hoshino S, Tachibana S, Watanabe T, Furuta K, Sekine S, Umaki T, Watabe Y, Miura N, Ono M, Tsuchida A, Yamada T.

Cancer Sci. 2013 Aug;104(8):1045-51. doi: 10.1111/cas.12187. Epub 2013 Jun 13.

9.

Neurocognitive deficits associated with the hepatitis C virus among incarcerated men.

Umaki TM, Denney RL.

Clin Neuropsychol. 2013;27(3):426-36. doi: 10.1080/13854046.2012.758315. Epub 2013 Jan 24.

PMID:
23343198
10.

The psychology of patient compliance: a focused review of the literature.

Umaki TM, Umaki MR, Cobb CM.

J Periodontol. 2012 Apr;83(4):395-400. doi: 10.1902/jop.2011.110344. Epub 2011 Aug 5. Review.

PMID:
21819248
11.

Expression and gene amplification of actinin-4 in invasive ductal carcinoma of the pancreas.

Kikuchi S, Honda K, Tsuda H, Hiraoka N, Imoto I, Kosuge T, Umaki T, Onozato K, Shitashige M, Yamaguchi U, Ono M, Tsuchida A, Aoki T, Inazawa J, Hirohashi S, Yamada T.

Clin Cancer Res. 2008 Sep 1;14(17):5348-56. doi: 10.1158/1078-0432.CCR-08-0075.

12.

Serum albumin-associated peptides of patients with uterine endometrial cancer.

Kikuchi S, Honda K, Handa Y, Kato H, Yamashita K, Umaki T, Shitashige M, Ono M, Tsuchida A, Aoki T, Hirohashi S, Yamada T.

Cancer Sci. 2007 Jun;98(6):822-9. Epub 2007 Apr 5.

13.

Possible prediction of chemoradiosensitivity of esophageal cancer by serum protein profiling.

Hayashida Y, Honda K, Osaka Y, Hara T, Umaki T, Tsuchida A, Aoki T, Hirohashi S, Yamada T.

Clin Cancer Res. 2005 Nov 15;11(22):8042-7.

14.

Possible detection of pancreatic cancer by plasma protein profiling.

Honda K, Hayashida Y, Umaki T, Okusaka T, Kosuge T, Kikuchi S, Endo M, Tsuchida A, Aoki T, Itoi T, Moriyasu F, Hirohashi S, Yamada T.

Cancer Res. 2005 Nov 15;65(22):10613-22.

Supplemental Content

Support Center